![Patient disposition. DMARD, disease-modifying antirheumatic drug; mITT,... | Download Scientific Diagram Patient disposition. DMARD, disease-modifying antirheumatic drug; mITT,... | Download Scientific Diagram](https://www.researchgate.net/publication/260195766/figure/fig2/AS:287878920851474@1445647091689/Figure1-Patient-disposition-DMARD-disease-modifying-antirheumatic-drug-mITT-modified.png)
Patient disposition. DMARD, disease-modifying antirheumatic drug; mITT,... | Download Scientific Diagram
![Phytochemical add-on therapy to DMARDs therapy in rheumatoid arthritis: In vitro and in vivo bases, clinical evidence and future trends - ScienceDirect Phytochemical add-on therapy to DMARDs therapy in rheumatoid arthritis: In vitro and in vivo bases, clinical evidence and future trends - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1043661821002024-ga1.jpg)
Phytochemical add-on therapy to DMARDs therapy in rheumatoid arthritis: In vitro and in vivo bases, clinical evidence and future trends - ScienceDirect
![Medicina | Free Full-Text | Diabetes-Modifying Antirheumatic Drugs: The Roles of DMARDs as Glucose-Lowering Agents Medicina | Free Full-Text | Diabetes-Modifying Antirheumatic Drugs: The Roles of DMARDs as Glucose-Lowering Agents](https://www.mdpi.com/medicina/medicina-58-00571/article_deploy/html/images/medicina-58-00571-g001.png)
Medicina | Free Full-Text | Diabetes-Modifying Antirheumatic Drugs: The Roles of DMARDs as Glucose-Lowering Agents
![Biomolecules | Free Full-Text | Biomarkers to Personalize the Treatment of Rheumatoid Arthritis: Focus on Autoantibodies and Pharmacogenetics Biomolecules | Free Full-Text | Biomarkers to Personalize the Treatment of Rheumatoid Arthritis: Focus on Autoantibodies and Pharmacogenetics](https://www.mdpi.com/biomolecules/biomolecules-10-01672/article_deploy/html/images/biomolecules-10-01672-g001.png)
Biomolecules | Free Full-Text | Biomarkers to Personalize the Treatment of Rheumatoid Arthritis: Focus on Autoantibodies and Pharmacogenetics
![Facilitators and Barriers to Adherence in the Initiation Phase of Disease-modifying Antirheumatic Drug (DMARD) Use in Patients with Arthritis Who Recently Started Their First DMARD Treatment | The Journal of Rheumatology Facilitators and Barriers to Adherence in the Initiation Phase of Disease-modifying Antirheumatic Drug (DMARD) Use in Patients with Arthritis Who Recently Started Their First DMARD Treatment | The Journal of Rheumatology](https://www.jrheum.org/content/jrheum/42/3/379/F1.large.jpg)
Facilitators and Barriers to Adherence in the Initiation Phase of Disease-modifying Antirheumatic Drug (DMARD) Use in Patients with Arthritis Who Recently Started Their First DMARD Treatment | The Journal of Rheumatology
![Drugs used for arthritis. Conventional Disease Modifying Anti-Rheumatic... | Download Scientific Diagram Drugs used for arthritis. Conventional Disease Modifying Anti-Rheumatic... | Download Scientific Diagram](https://www.researchgate.net/publication/343107336/figure/fig1/AS:915774751379457@1595349123112/Drugs-used-for-arthritis-Conventional-Disease-Modifying-Anti-Rheumatic-Drugs-DMARDs.png)
Drugs used for arthritis. Conventional Disease Modifying Anti-Rheumatic... | Download Scientific Diagram
![Does treatment strategy influence the ability to achieve and sustain DMARD-free remission in patients with RA? Results of an observational study comparing an intensified DAS-steered treatment strategy with treat to target in Does treatment strategy influence the ability to achieve and sustain DMARD-free remission in patients with RA? Results of an observational study comparing an intensified DAS-steered treatment strategy with treat to target in](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13075-019-1893-z/MediaObjects/13075_2019_1893_Fig1_HTML.png)
Does treatment strategy influence the ability to achieve and sustain DMARD-free remission in patients with RA? Results of an observational study comparing an intensified DAS-steered treatment strategy with treat to target in
![Cureus | The Cost-Effectiveness of and Adherence to Disease-Modifying Antirheumatic Drug (DMARD) Therapy in Rheumatoid Arthritis Patients in a Tertiary Care Teaching Hospital in Uttarakhand, India | Article Cureus | The Cost-Effectiveness of and Adherence to Disease-Modifying Antirheumatic Drug (DMARD) Therapy in Rheumatoid Arthritis Patients in a Tertiary Care Teaching Hospital in Uttarakhand, India | Article](https://assets.cureus.com/uploads/figure/file/553302/article_river_daa33a10a5d911ed90499bb4f81ced1f-lightbox_69f434e0a39511ed867f1f71aa951fde-figure-1.png)
Cureus | The Cost-Effectiveness of and Adherence to Disease-Modifying Antirheumatic Drug (DMARD) Therapy in Rheumatoid Arthritis Patients in a Tertiary Care Teaching Hospital in Uttarakhand, India | Article
![Schematic of the trial design. DMARD disease modifying antirheumatic... | Download Scientific Diagram Schematic of the trial design. DMARD disease modifying antirheumatic... | Download Scientific Diagram](https://www.researchgate.net/publication/293011719/figure/fig1/AS:329964294557697@1455681026519/Schematic-of-the-trial-design-DMARD-disease-modifying-antirheumatic-drugs-ETN.png)
Schematic of the trial design. DMARD disease modifying antirheumatic... | Download Scientific Diagram
![EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update | Annals of the Rheumatic Diseases EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update | Annals of the Rheumatic Diseases](https://ard.bmj.com/content/annrheumdis/73/3/492/F1.large.jpg)
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update | Annals of the Rheumatic Diseases
![Biologic and Targeted Synthetic DMARD Utilization in the United States: Adelphi Real World Disease Specific Programme for Rheumatoid Arthritis | Rheumatology and Therapy Biologic and Targeted Synthetic DMARD Utilization in the United States: Adelphi Real World Disease Specific Programme for Rheumatoid Arthritis | Rheumatology and Therapy](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40744-021-00357-1/MediaObjects/40744_2021_357_Fig4_HTML.png)